Simplified Premium Plans with 40% discount

published in Blogs

Mar 23, 2022

We have been receiving numerous suggestions to simplify ways of selection of our premium products. As a result, we come up with a new page where we recommend groups of products as plans. In addition, we introduced annual plans which provide a 40% discount.

https://tickeron.com/app/user/memberships/level

Contributor

Allana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.

Interact to see
Advertisement

UBS vs HSBC: Earnings Preview as Q4 Results Could Shift European Bank Sentiment

UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.

UBS HSBC #MajorBanks

Arthur Evans, expert

Feb 09, 2026

Datadog (DDOG) Stock Analysis: AI Growth Narrative Intact After Sharp Pullback

Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.

DDOG #PackagedSoftware

Dem Sem, expert

Feb 11, 2026

Starbucks (SBUX) Stock Analysis: Turnaround Momentum Gains Traction

Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.

SBUX #Restaurants

Dem Sem, expert

Feb 10, 2026

DoorDash (DASH) Stock Analysis: Managing Volatility Amid Delivery Sector Pressures

DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.

DASH #InternetRetail

Dem Sem, expert

Feb 11, 2026

Amazon.com (AMZN) Q4 2025 Earnings Recap: Revenue Beat Overshadowed by AI Capex Shock

Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.

AMZN #InternetRetail

Dem Sem, expert

Feb 09, 2026

ConocoPhillips (COP) Q4 2025 Earnings Recap: Production Gains Cushion EPS Miss

ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.

COP #OilGasProduction

Dem Sem, expert

Feb 13, 2026

LLY vs JNJ Stock Comparison: Q4 2025 Earnings and 2026 Guidance

Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.

LLY JNJ #PharmaceuticalsMajor

Dem Sem, expert

Feb 10, 2026

NVO vs NVS Stock Comparison: Q4 2025 Earnings Recap and Outlook

Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.

NVO NVS #PharmaceuticalsMajor

Dem Sem, expert

Feb 11, 2026

MUFG vs HSBC Stock Comparison: Earnings Preview Amid Global Banking Shifts

MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.

MUFG HSBC #MajorBanks

Dem Sem, expert

Feb 13, 2026

Gogo Inc. (GOGO) Stock Analysis: Balancing 5G Momentum Against Competitive Pressures

Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.

GOGO #MajorTelecommunications

Abhoy Sarkar, expert

Feb 15, 2026

Quantum Computing Inc. (QUBT) Stock Analysis: Photonics Strategy Redefines Growth Outlook

Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.

QUBT #ComputerProcessingHardware

Abhoy Sarkar, expert

Feb 16, 2026

Energy Recovery Inc. (ERII) Stock Analysis: Capitalizing on Rising Desalination Demand

ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.

ERII #IndustrialSpecialties

Abhoy Sarkar, expert

Feb 20, 2026

Golar LNG (GLNG) Stock Analysis: FLNG Expansion Drives Earnings Momentum

Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.

GLNG #OilGasPipelines

Abhoy Sarkar, expert

Feb 09, 2026

Liberty Broadband Corporation (LBRDA) Stock Analysis: Volatility Builds Around Charter Merger

Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.

LBRDA #MajorTelecommunications

Abhoy Sarkar, expert

Feb 21, 2026

Apollo Global Management (APO) Earnings Preview: Q4 Expectations Highlight Growth Trajectory

Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.

APO #InvestmentManagers

Abhoy Sarkar, expert

Feb 16, 2026

CINF vs ALL Stock Comparison: Earnings Preview Ahead of Q4 Results

Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.

CINF ALL #PropertyCasualtyInsurance

Abhoy Sarkar, expert

Feb 13, 2026

KO vs PEP Stock Comparison: Q4 Earnings Preview

Coca-Cola (KO) reports Q4 2025 earnings on February 10, 2026, with consensus EPS of $0.56 and revenue of $12.05 billion. PepsiCo (PEP) beat Q4 2025 estimates on February 3, reporting adjusted EPS of $2.26 (vs. $2.24 expected) and revenue of $29.34 billion.

KO PEP #BeveragesNonAlcoholic

Abhoy Sarkar, expert

Feb 09, 2026

AstraZeneca (AZN) Earnings Preview: Growth Momentum Meets High Expectations

(AZN) AstraZeneca’s full-year 2025 results, set for February 10, 2026, cap a year of sustained growth amid competitive pressures. Following 21% total revenue growth in FY 2024 and 19% core EPS expansion, AZN has maintained momentum with 11% revenue growth through nine months of 2025. The report offers insight into:

AZN #PharmaceuticalsMajor

Abhoy Sarkar, expert

Feb 10, 2026

GILD vs AMGN Stock Comparison: Earnings Preview Ahead of Q4

Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.

GILD AMGN #PharmaceuticalsMajor

Abhoy Sarkar, expert

Feb 11, 2026

Arm Holdings (ARM) Stock Analysis: AI Expansion Redefines the Growth Narrative

Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.

Dem Sem, expert

Feb 21, 2026